drugset / Trial / NCT06796725

Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG

NCT06796725

Recruiting 60 enrolled Ruijin Hospital
RandomizedCrossoverSingle-blindTreatment

Summary

Using magnetoencephalography to locate and regulate targets in migraine patients, repeating transcranial magnetic stimulation to physically regulate targets, and evaluating the safety and effectiveness of this treatment method through headache related scales. Using whole genome data and scale scores for correlation analysis, and conducting randomized controls with traditional drugs to explore new approaches for migraine.

Timeline

Start
2025-02-06
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Flunarizine Small molecule 10 mg Oral

Indications